Su-Chun Cheng

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
Su Chun Cheng, Suchun Cheng, Su‐chun Cheng
Publication record
95 papers · 4,846 citations · H-index 34

PAPERS

Report on the PET/CT Image–Based Radiation Dosimetry of [18F]FDHT in Women, a Validated Imaging Agent with New Applications for Evaluation of Androgen Receptor Status in Women with Metastatic Breast Cancer
20230 citationsauthor #3
Activity of combination trametinib/navitoclax in patients with RAS-mutated gynecologic (GYN) cancers in a Phase 1/2 study (LBA 12)
20220 citationsauthor #9
Use of Fluoro-[18F]-Deoxy-2-D-Glucose Positron Emission Tomography/Computed Tomography to Predict Immunotherapy Treatment Response in Patients With Squamous Cell Oral Cavity Cancers.
202211 citationsauthor #3
A Phase II, Two-Stage Study of Letrozole and Abemaciclib in Estrogen Receptor–Positive Recurrent Endometrial Cancer
202260 citationsauthor #19
Evaluation of Treatment With Talazoparib and Avelumab in Patients With Recurrent Mismatch Repair Proficient Endometrial Cancer
202241 citationsauthor #17
Phase 2, two-stage study of letrozole and abemaciclib in estrogen receptor (ER) positive recurrent or persistent endometrial cancer (072)
20221 citationsauthor #10
Improved T-cell Immunity Following Neoadjuvant Chemotherapy in Ovarian Cancer
202223 citationsauthor #10
A Replication stress biomarker is associated with response to gemcitabine versus combined gemcitabine and ATR inhibitor therapy in ovarian cancer
202150 citationsauthor #5
Combined PARP and HSP90 inhibition: preclinical and Phase 1 evaluation in patients with advanced solid tumours
202127 citationsauthor #2
Imaging Androgen Receptors in Breast Cancer with 18F-Fluoro-5α-Dihydrotestosterone PET: A Pilot Study
202116 citationsauthor #3
Improved Quantification of Cardiac Amyloid Burden in Systemic Light Chain Amyloidosis: Redefining Early Disease?
202069 citationsauthor #13
Berzosertib plus gemcitabine versus gemcitabine alone in platinum-resistant high-grade serous ovarian cancer: a multicentre, open-label, randomised, phase 2 trial.
2020172 citationsauthor #2
Discrepancy between FDG-PET/CT and contrast-enhanced CT in the staging of patients with inflammatory breast cancer: implications for treatment planning
202018 citationsauthor #5
Combined pembrolizumab and pegylated liposomal doxorubicin in platinum resistant ovarian cancer: A phase 2 clinical trial.
202077 citationsauthor #3
Utility of FDG-PET/CT in Patients with Advanced Renal Cell Carcinoma with Osseous Metastases: Comparison with CT and 99mTc-MDP Bone Scan in a Prospective Clinical Trial
20191 citationsauthor #3
Abstract A074: Correlation of homologous recombination deficiency (HRD) status by BROCA-HR sequencing with response to combination cediranib and olaparib in relapsed ovarian cancer
20190 citationsauthor #2
Metabolic Characterization of Inflammatory Breast Cancer With Baseline FDG‐PET/CT: Relationship With Pathologic Response After Neoadjuvant Chemotherapy, Receptor Status, and Tumor Grade
20194 citationsauthor #5
Normalization of ADC does not improve correlation with overall survival in patients with high-grade glioma (HGG)
201817 citationsauthor #6
Effects of hyperglycemia on fluorine-18-fluorodeoxyglucose biodistribution in a large oncology clinical practice
20188 citationsauthor #2
Surveillance Imaging in Patients With Endometrial Cancer in First Remission.
20173 citationsauthor #2
Characterization of serum anti-diphtheria antibody activity following administration of equine anti-toxin for suspected diphtheria
20174 citationsauthor #5
Phase 2 Study of Bevacizumab and Temsirolimus After VEGFR TKI in Metastatic Renal Cell Carcinoma.
201613 citationsauthor #7
Killer immunoglobulin-like receptor (KIR) and KIR–ligand genotype do not correlate with clinical outcome of renal cell carcinoma patients receiving high-dose IL2
20167 citationsauthor #10
Penetrance of ATM Gene Mutations in Breast Cancer: A Meta‐Analysis of Different Measures of Risk
2016149 citationsauthor #2
FCGR Polymorphisms Influence Response to IL2 in Metastatic Renal Cell Carcinoma
201616 citationsauthor #11
( 18 F)-Fluorodeoxyglucose
20150 citationsauthor #2
[18F]-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography of LAPC4-CR Castration-Resistant Prostate Cancer Xenograft Model in Soft Tissue Compartments1 The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters
20152 citationsauthor #2
Demonstrating the Advantages of Applying Data Mining Techniques on Time-Dependent Electronic Medical Records
20156 citationsauthor #3
Differential Expression of PD-L1 between Primary and Metastatic Sites in Clear-Cell Renal Cell Carcinoma
2015253 citationsauthor #5
[18F]-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography of LAPC4-CR Castration-Resistant Prostate Cancer Xenograft Model in Soft Tissue Compartments1
20154 citationsauthor #2
[ 18 F ]-Fluorodeoxyglucose Positron Emission Tomography / Computed Tomography of LAPC 4-CR Castration-Resistant Prostate Cancer Xenograft Model in Soft Tissue Compartments 1
20152 citationsauthor #2
positron emission tomography computed tomography of LAPC4-CR castration-resistant prostate cancer xenograft mod in soft tissue compartments
20150 citationsauthor #2
Recent BRCAPRO Upgrades Significantly Improve Calibration
201424 citationsauthor #3
Validation of FDG Uptake in the Arterial Wall as an Imaging Biomarker of Atherosclerotic Plaques with 18F‐Fluorodeoxyglucose Positron Emission Tomography‐Computed Tomography (FDG‐PET/CT)
201412 citationsauthor #6
NATURAL LANGUAGE PROCESSING IMPROVES PHENOTYPIC ACCURACY IN AN ELECTRONIC MEDICAL RECORD COHORT OF TYPE 2 DIABETES AND CARDIOVASCULAR DISEASE
201419 citationsauthor #3
The High-Dose Aldesleukin “Select” Trial: A Trial to Prospectively Validate Predictive Models of Response to Treatment in Patients with Metastatic Renal Cell Carcinoma
2014139 citationsauthor #2
Su1324 Serum Inflammatory Markers and Risk of Colorectal Cancer in Patients With Inflammatory Bowel Disease
20140 citationsauthor #2
Evolution of CT Imaging Features of Carotid Atherosclerotic Plaques in a 1‐Year Prospective Cohort Study
201420 citationsauthor #4
Thromboprophylaxis is associated with reduced post-hospitalization venous thromboembolic events in patients with inflammatory bowel diseases.
201469 citationsauthor #4
Serum inflammatory markers and risk of colorectal cancer in patients with inflammatory bowel diseases.
201452 citationsauthor #2
Mortality and extraintestinal cancers in patients with primary sclerosing cholangitis and inflammatory bowel disease.
201455 citationsauthor #4
A phase II study of bevacizumab (Bev) and temsirolimus (Tem) in VEGF-refractory metastatic renal cell carcinoma (mRCC).
20140 citationsauthor #2
Higher plasma 25(OH)D is associated with reduced risk of Clostridium difficile infection in patients with inflammatory bowel diseases
20145 citationsauthor #4
Mo1263 Higher Plasma Vitamin D is Associated With Reduced Risk of Clostridium difficile Infection in Patients With Inflammatory Bowel Disease
20141 citationsauthor #4
302 Extraintestinal Cancers and Mortality in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Disease
20140 citationsauthor #3
Mo1262 Pharmacologic Thromboprophylaxis Reduces Post-Hospitalization Venous Thromboembolic Events in Patients With Inflammatory Bowel Disease
20140 citationsauthor #4
Improving Case Definition of Crohns Disease and Ulcerative Colitis in Electronic Medical Records Using Natural Language Processing
20133 citationsauthor #4
Improving Case Definition of Crohn's Disease and Ulcerative Colitis in Electronic Medical Records Using Natural Language Processing: A Novel Informatics Approach
2013168 citationsauthor #4
Modeling Disease Severity in Multiple Sclerosis Using Electronic Health Records
201379 citationsauthor #5
Normalization of Plasma 25-Hydroxy Vitamin D Is Associated with Reduced Risk of Surgery in Crohn’s Disease
2013209 citationsauthor #5
221 Psychiatric Co-Morbidity Is Associated With Increased Risk of Surgery in Crohns Disease
20131 citationsauthor #4
Similar Risk of Depression and Anxiety Following Surgery or Hospitalization for Crohn's Disease and Ulcerative Colitis
2013100 citationsauthor #5
Demographics of carotid atherosclerotic plaque features imaged by computed tomography.
20139 citationsauthor #3
Pdl-1/pdl-3 (programmed death ligand-1/3) tissue expression and response to treatment with IL2 and antiangiogenic therapies.
201310 citationsauthor #2
Association between reduced plasma 25-hydroxy vitamin D and increased risk of cancer in patients with inflammatory bowel diseases.
2013110 citationsauthor #2
SQSTM1 is a pathogenic target of 5q copy number gains in kidney cancer.
2013160 citationsauthor #14
The penetrance of ductal carcinoma in situ among BRCA1 and BRCA2 mutation carriers
20129 citationsauthor #2
Perfusion-CT assessment of blood-brain barrier permeability in patients with aneurysmal subarachnoid hemorrhage.
201214 citationsauthor #8
Landmark Prediction of Long-Term Survival Incorporating Short-Term Event Time Information
201230 citationsauthor #2
Diaphragm Used with Replens Gel and Risk of Bacterial Vaginosis: Results from a Randomized Controlled Trial
20123 citationsauthor #2
Estimating Regression Parameters in an Extended Proportional Odds Model
20128 citationsauthor #3
Contrast Delay on Perfusion CT as a Predictor of New, Incident Infarct: A Retrospective Cohort Study
201219 citationsauthor #5
Evaluation of patient-reported quality-of-life outcomes after renal surgery.
201217 citationsauthor #3
Tu1278 Body Mass Index in the Aetiology of Inflammatory Bowel Disease - Data From a European Prospective Cohort Study (EPIC)
20122 citationsauthor #3
Orthotopic xenografts of RCC retain histological, immunophenotypic and genetic features of tumours in patients
201137 citationsauthor #6
Incorporating short‐term outcome information to predict long‐term survival with discrete markers
201119 citationsauthor #2
1077 INTERNET-BASED EVALUATION OF QUALITY-OF-LIFE OUTCOMES AFTER ROBOTIC, LAPAROSCOPIC, AND OPEN RADICAL OR PARTIAL NEPHRECTOMY
20110 citationsauthor #2
Infection-Related Hospitalizations in Older Patients With End-Stage Renal Disease
20105 citationsauthor #4
Carotid Atherosclerosis Does Not Predict Coronary, Vertebral, or Aortic Atherosclerosis in Patients With Acute Stroke Symptoms
201020 citationsauthor #4
Reperfusion Is a More Accurate Predictor of Follow-Up Infarct Volume Than Recanalization: A Proof of Concept Using CT in Acute Ischemic Stroke Patients
2010177 citationsauthor #4
Infection-related hospitalizations in older patients with ESRD.
2010111 citationsauthor #4
Performance Characteristics of Anal Cytology and Human Papillomavirus Testing in Patients with High-Resolution Anoscopy-Guided Biopsy of High-Grade Anal Intraepithelial Neoplasia
2009196 citationsauthor #4
Individualized asthma self-management improves medication adherence and markers of asthma control.
2009212 citationsauthor #4
Comparison of Patient- and Clinician-Collected Anal Cytology Samples to Screen for Human PapillomavirusAssociated Anal Intraepithelial Neoplasia in Men Who Have Sex with Men
2008155 citationsauthor #3
Trends and outcomes associated with serum albumin concentration among incident dialysis patients in the United States.
200846 citationsauthor #3
Accuracy and Anatomical Coverage of Perfusion CT Assessment of the Blood-Brain Barrier Permeability: One Bolus versus Two Boluses
200816 citationsauthor #4
Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group study
2008551 citationsauthor #3
Phase II study on the effect of disease sites, age, and prior therapy on response to iodine-131-metaiodobenzylguanidine therapy in refractory neuroblastoma.
2007231 citationsauthor #6
Factors Influencing Survival after Relapse from Childhood ALL: A Children’s Oncology Group Study.
20065 citationsauthor #2
Linear life expectancy regression with censored data
200662 citationsauthor #2
Evaluation of semi‐quantitative scoring system for metaiodobenzylguanidine (mIBG) scans in patients with relapsed neuroblastoma
200686 citationsauthor #2
Semiparametric regression analysis of mean residual life with censored survival data
200583 citationsauthor #2
A phase II study of 131I-MIBG for refractory neuroblastoma
20050 citationsauthor #9
Phase I dose-escalation study of the SRC and multi-kinase inhibitor BMS-354825 in patients (pts) with GIST and other solid tumors
200528 citationsauthor #8
Tumor response and toxicity with multiple infusions of high dose 131I‐MIBG for refractory neuroblastoma
200589 citationsauthor #5
Semiparametric regression analysis for doubly censored data
200468 citationsauthor #2
Mean Response Models of Repeated Measurements in Presence of Varying Effectiveness Onset
20040 citationsauthor #2
Comparative efficacy and safety of gemtuzumab ozogamicin monotherapy and high-dose cytarabine combination therapy in patients with acute myeloid leukemia in first relapse.
200319 citationsauthor #3
Independent prognostic significance of day 21 cytogenetic findings in newly-diagnosed acute myeloid leukemia or refractory anemia with excess blasts.
200310 citationsauthor #2
Linear Transformation Models for Failure Time Data With Covariate Measurement Error
200117 citationsauthor #1
Optimal two‐stage designs for clinical trials based on safety and efficacy
200128 citationsauthor #2
Long-Term O utcome o f P atients W ith A merican J oint Committee o n C ancer S tage I IB E xtremity Soft T issue S arcomas
19990 citationsauthor #3
Long-term outcome of patients with American Joint Committee on Cancer stage IIB extremity soft tissue sarcomas.
199960 citationsauthor #3
Preoperative chemotherapy for stage IIIB extremity soft tissue sarcoma: long-term results from a single institution.
1997113 citationsauthor #4
Serum levels of soluble CD8, neopterin, β2‐microglobulin and p24 antigen as indicators of disease progression in children with AIDS on zidovudine therapy
19937 citationsauthor #6

TIMELINE

1993 7 citations

1997 113 citations

1999 60 citations

2001 45 citations

2003 29 citations

2004 68 citations

2005 200 citations

2006 153 citations

2007 231 citations

2008 768 citations

2009 408 citations

2010 313 citations

2011 56 citations

2012 102 citations

2013 849 citations

2014 396 citations

2015 267 citations

2016 185 citations

2017 7 citations

2018 25 citations

2019 5 citations

2020 336 citations

2021 93 citations

2022 136 citations

2023 0 citations

Su-Chun Cheng

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT